# An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults

> **NCT07016152** · PHASE1 · RECRUITING · sponsor: **Cho Pharma Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Klebsiella Pneumoniae Infection
- Vaccine

## Interventions

- **BIOLOGICAL:** Glyconjugate Klebsiella pneumoniae bivalent vaccine

## Key facts

- **NCT ID:** NCT07016152
- **Lead sponsor:** Cho Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-26
- **Primary completion:** 2026-11-05
- **Final completion:** 2027-04-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016152, "An Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of a Bivalent Klebsiella Pneumoniae Vaccine (CHO-V08) in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07016152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*